Nephrogen
Curative gene therapies for kidney diseases
We're building curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
Active Founders
Demetri Maxim, Founder
Stanford B.S. '20 (Biology), Founder of Nephrogen
